"Bone and Bones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
| Descriptor ID |
D001842
|
| MeSH Number(s) |
A02.835.232 A10.165.265
|
| Concept/Terms |
Bone Tissue- Bone Tissue
- Bone Tissues
- Tissue, Bone
- Tissues, Bone
- Bony Apophyses
- Apophyses, Bony
- Bony Apophysis
- Apophysis, Bony
|
Below are MeSH descriptors whose meaning is more general than "Bone and Bones".
Below are MeSH descriptors whose meaning is more specific than "Bone and Bones".
This graph shows the total number of publications written about "Bone and Bones" by people in this website by year, and whether "Bone and Bones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 2 | 2 |
| 1998 | 3 | 1 | 4 |
| 2000 | 4 | 3 | 7 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 7 | 3 | 10 |
| 2005 | 5 | 2 | 7 |
| 2006 | 2 | 3 | 5 |
| 2007 | 8 | 4 | 12 |
| 2008 | 6 | 1 | 7 |
| 2009 | 2 | 3 | 5 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 3 | 5 |
| 2012 | 4 | 3 | 7 |
| 2013 | 3 | 2 | 5 |
| 2014 | 14 | 4 | 18 |
| 2015 | 10 | 0 | 10 |
| 2016 | 0 | 3 | 3 |
| 2017 | 11 | 4 | 15 |
| 2018 | 7 | 2 | 9 |
| 2019 | 4 | 9 | 13 |
| 2020 | 4 | 2 | 6 |
| 2021 | 4 | 9 | 13 |
| 2022 | 1 | 5 | 6 |
| 2023 | 2 | 4 | 6 |
| 2024 | 3 | 5 | 8 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone and Bones" by people in Profiles.
-
Metabolomic evaluation of air pollution-related bone damage and potential mediation in Women's Health Initiative participants. J Bone Miner Res. 2025 Jun 25; 40(7):834-846.
-
Anti-transforming growth factor-? treatment shows increased bone mass and strength in a novel mouse model for osteogenesis imperfecta type I. J Bone Miner Res. 2025 Jun 25; 40(7):881-890.
-
High-Fidelity Finite Element Modeling Technique to Improve Sensitivity to Bone Tissue Changes of Older Adults with Obesity undergoing Intensive Lifestyle Intervention. Ann Biomed Eng. 2025 Sep; 53(9):2359-2371.
-
Pharmacogenetic and microRNA mechanisms of beta blocker use on bone. J Bone Miner Res. 2025 Feb 02; 40(2):231-240.
-
Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism. Clin Chem Lab Med. 2025 Mar 26; 63(4):704-711.
-
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer. Commun Biol. 2024 Nov 21; 7(1):1545.
-
Bone-targeted ultrasound-responsive nanobubbles for siRNA delivery to treat osteoporosis in mice. Biomater Adv. 2025 Jan; 166:214078.
-
Skeletal and Non-skeletal Phenotypes in Children with Osteogenesis Imperfecta. Calcif Tissue Int. 2024 Dec; 115(6):923-930.
-
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nat Med. 2024 Sep; 30(9):2605-2612.
-
Measurement of?energy availability in highly trained male endurance athletes and examination of its associations with bone health and endocrine function. Eur J Nutr. 2024 Oct; 63(7):2655-2665.